HIV-1 中和抗体は,幼児から限られたハイパーミューテーションを持つ
Cassandra A Simonich1, Katherine L Williams2, Hans P Verkerke3
1Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Medical Scientist Training Program, University of Washington School of Medicine, Seattle, WA 98195, USA.
Cell
|June 28, 2016
まとめ
乳児は感染後すぐにHIV-1に対する広範な中和性抗体 (bnAbs) を形成し,新しいワクチン接種戦略を提供することができます. この研究では,低体性高変異 (SHM) を有する複数のHIV株を中和する乳児のbnAbが特定されました.
科学分野:
- 免疫学
- ウイルス学
- ワクチン学
背景:
- 成人は長年の親和性成熟と高体性高変異 (SHM) の後,HIV-1を広く中和する抗体 (bnAbs) を形成する.
- ワクチン接種で高度に変異した抗体を誘発することは困難で時間がかかります.
- 乳児は早期に広範な免疫反応を発現し bnAbsへのより直接的な経路を示唆しています
研究 の 目的:
- 乳児が成人 bnAbs と比較して異なる特徴を持つbnAbs を生成できるかどうかを調査する.
- 乳児のHIV-1感染による新しいbnAbsを特定し,ワクチン開発を促す.
主な方法:
- HIV-1感染から約1年後の乳児の血から10個の中和抗体 (nAbs) の分離と特徴づけ.
- 感染したウイルスの封筒トリマーに結合する抗体の分析
- 特定されたクロスクラードbnAbの特徴の詳細な調査,SHMとN332スーパーサイトのターゲット付けを含む.
主要な成果:
- 乳児の血から10個のnAbsが分離され,中和の幅に寄与しました.
- 単離された抗体はクロスクラード幅を示し,複数のHIV-1株を中和させました.
- この赤ん坊のクロスクラードbnAbはN332スーパーサイトをターゲットとするが,同じサイトをターゲットとする成人bnAbsとは異なり,SHMが低く,インデルが欠けている.
結論:
- HIV-1 中和の幅は,大人に見られる広範なSHMと長時間の親和性成熟なしに乳児で達成できます.
- 発見は,乳児の早期HIV-1感染が効果的なbnAbsを生成するためのより直接的な経路を提供することを示唆しています.
- この赤ん坊のbnAbは,強力で広範な中和反応を効率的に誘導する次世代のHIVワクチンの開発のための新しいターゲットを表しています.
さらに関連する動画
関連する概念動画
01:22Development of Immunocompetence
1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
01:29Immune Response Against Viral Pathogens
2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
01:10Retrovirus Life Cycles
50.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.3K
01:25Immunodeficiency Diseases
2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.7K